Hirokazu Konishi
Overview
Explore the profile of Hirokazu Konishi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang L, Okugawa M, Konishi H, Liu Y, Koizumi Y, Nakano T
Materials (Basel)
. 2023 Aug;
16(15).
PMID: 37570152
The limited wear resistance of commercially pure titanium (CP-Ti) hinders its use in abrasive and erosive environments, despite its good strength-weight ratio and corrosion resistance. This paper reports the first...
2.
Konishi H, Koshida R, Habara M, Nasu K, Hirano K, Kinoshita Y, et al.
J Endovasc Ther
. 2021 Nov;
29(4):536-543.
PMID: 34758672
Purpose: The endovascular approach for eccentric calcified lesions of the no-stenting zone is challenging. This study aimed to investigate the effect of a novel technique for these lesions. Methods: We...
3.
Konishi H, Habara M, Nasu K, Koshida R, Kinoshita Y, Tsuchikane E, et al.
Cardiovasc Revasc Med
. 2021 Mar;
35:91-95.
PMID: 33766488
Background: Drug eluting stent (DES) remain several problems, including stent thrombosis, stent fracture and neoatherosclerosis. Stent-less Percutaneous coronary intervention (PCI) using a drug coated balloon (DCB) is a stent-less strategy,...
4.
Shitara J, Naito R, Kasai T, Endo H, Wada H, Doi S, et al.
BMC Cardiovasc Disord
. 2021 Jan;
21(1):36.
PMID: 33446110
Background: The aim of this study was to determine the difference in effects of beta-blockers on long-term clinical outcomes between ischemic heart disease (IHD) patients with mid-range ejection fraction (mrEF)...
5.
Konishi H, Miyauchi K, Onishi A, Suzuki S, Fuchimoto D, Shitara J, et al.
PLoS One
. 2020 Nov;
15(11):e0241195.
PMID: 33201888
Background: Peroxisome proliferator-activated receptor α (PPARα) is a nuclear receptor that has key roles of lipid metabolism and inflammation. The PPARα may affects the initiation and progression of atherosclerosis by...
6.
Shitara J, Kasai T, Konishi H, Endo H, Wada H, Doi S, et al.
Circ J
. 2019 Mar;
83(5):1047-1053.
PMID: 30918220
Background: Serum levels of lipoprotein (a) (Lp(a)) could be a risk factor for adverse events in patients with coronary artery disease (CAD). However, the effect of Lp(a) on long-term outcomes...
7.
Endo H, Dohi T, Funamizu T, Shitara J, Wada H, Doi S, et al.
Circ J
. 2018 Dec;
83(3):630-636.
PMID: 30541988
Background: High-sensitivity C-reactive protein (hs-CRP) is a well known risk factor for the development of cardiovascular disease and cancer. We investigated the long-term impact of hs-CRP on cancer mortality in...
8.
Shitara J, Ogita M, Wada H, Tsuboi S, Endo H, Doi S, et al.
J Cardiol
. 2018 Jul;
73(1):45-50.
PMID: 30001869
Introduction: C-reactive protein (CRP) is an established marker for vascular inflammation and predictor of adverse cardiovascular events, but the prognostic value of preprocedural CRP in coronary artery disease (CAD) patients...
9.
Doi S, Iwata H, Wada H, Funamizu T, Shitara J, Endo H, et al.
Int J Cardiol
. 2018 May;
262:92-98.
PMID: 29706396
Objective: No nutritional index has been firmly established yet in patients with coronary artery disease (CAD). In this study, we propose a simple to calculate nutritional indicator in patients who...
10.
Endo H, Dohi T, Shitara J, Wada H, Doi S, Naito R, et al.
J Cardiol
. 2018 Mar;
72(3):208-214.
PMID: 29550145
Background: The prognostic long-term impact of body mass index (BMI) on East Asian patients with coronary artery disease remains unclear. Methods: An observational retrospective cohort study was carried out involving...